Skip to main content

Table 4 Effect on STV, DTZ, and their combinations on perfusate biomarker levels in IRI

From: Evaluation of cardioprotection and bio-efficacy enhancement of stevioside and diltiazem in rats

Treatment Perfusate level (U/L)
ALT AST
IRI control 17.08 ± 1.08 37.37 ± 1.23
DTZ 22.46 ± 0.88** 51.39 ± 3.31***
STV 100 18.25 ± 0.62*** 42.08 ± 3.13***
STV 200 16.97 ± 0.99*** 30.12 ± 1.22***
STV 100 + DTZ 9.37 ± 1.30***ο 19.10 ± 1.15***οοο
STV 200 + DTZ 32.19 ± 2.97 72.44 ± 3.27
  1. Results are expressed as mean ± SEM, n = 8
  2. *P < 0.05
  3. **P < 0.01
  4. ***P < 0.001 when compared to IRI control
  5. οP < 0.05
  6. οοοP < 0.001 when compared to DTZ